Given that IL4i1 activates anti-ferroptosis pathways through I3P and possibly other indoles, we speculate that blocking IL4i1-mediated Trp metabolism could be a useful anti-cancer therapeutic strategies (Figure 3). This evidence concerns the gene IL4I1 and cancer.